We have previously characterized the hearing dysfunction affecting patients with DOA due to missense mutations in the OPA1 gene (Santarelli et al., 2015), who display impaired speech perception, severe abnormalities of ABRs and presence of OAEs consistent with auditory neuropathy. This evidence concerns the gene OPA1 and auditory neuropathy.